BDBM37550 3-[4-(2,5-dimethoxyphenyl)-5-(2-methylallylthio)-1,2,4-triazol-3-yl]-N,N-dimethyl-benzenesulfonamide::3-[4-(2,5-dimethoxyphenyl)-5-(2-methylprop-2-enylsulfanyl)-1,2,4-triazol-3-yl]-N,N-dimethyl-benzenesulfonamide::3-[4-(2,5-dimethoxyphenyl)-5-(2-methylprop-2-enylsulfanyl)-1,2,4-triazol-3-yl]-N,N-dimethylbenzenesulfonamide::3-[4-(2,5-dimethoxyphenyl)-5-(2-methylprop-2-enylthio)-1,2,4-triazol-3-yl]-N,N-dimethylbenzenesulfonamide::MLS000053160::SMR000067266::cid_2081422
SMILES COc1ccc(OC)c(c1)-n1c(SCC(C)=C)nnc1-c1cccc(c1)S(=O)(=O)N(C)C
InChI Key InChIKey=FJJLOGXCONQPFN-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 37550
TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Affinity DataIC50: >8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair